Allogene Therapeutics, Inc.
FORMULATIONS AND PROCESSES FOR CAR T CELL DRUG PRODUCTS

Last updated:

Abstract:

Provided herein are formulations and drug product processes that can improve cell viability and minimize waste of the manufactured formulated cells for a drug product.

Status:
Application
Type:

Utility

Filling date:

3 Feb 2022

Issue date:

4 Aug 2022